Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(2)

Detailed Status

Completed3
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

withdrawn120%
completed360%
terminated120%

Recent Activity

0 active trials
Showing 5 of 5
terminatednot_applicable

High Cut-Off Continuous Veno-venous Hemodialysis (CVVHD) in Patients Treated for Acute Renal Failure After Systemic Inflammatory Response Syndrome (SIRS)/Septic Shock

NCT00875888
completed

Chloride Transfer During Continuous Renal Replacement Therapy in the Intensive Care Unit: a Prospective Observational Cohort Study

NCT04755491
withdrawn

Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement Therapy

NCT01926301
completed

Norwegian Intensive Care Unit Dalteparin Effect Study

NCT01721928
completed

Influence Continuous Veno-venous Hemodialysis the Autoregulation

NCT01376531

Clinical Trials (5)

Showing 5 of 5 trials
NCT00875888Not Applicable

High Cut-Off Continuous Veno-venous Hemodialysis (CVVHD) in Patients Treated for Acute Renal Failure After Systemic Inflammatory Response Syndrome (SIRS)/Septic Shock

Terminated
NCT04755491

Chloride Transfer During Continuous Renal Replacement Therapy in the Intensive Care Unit: a Prospective Observational Cohort Study

Completed
NCT01926301

Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement Therapy

Withdrawn
NCT01721928

Norwegian Intensive Care Unit Dalteparin Effect Study

Completed
NCT01376531

Influence Continuous Veno-venous Hemodialysis the Autoregulation

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5